REPLIGEN ($RGEN) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of $0.49 per share, beating estimates of $0.45 by $0.04. The company also reported revenue of $197,910,000, beating estimates of $196,765,027 by $1,144,973.
You can see Quiver Quantitative's $RGEN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
REPLIGEN Insider Trading Activity
REPLIGEN insiders have traded $RGEN stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $RGEN stock by insiders over the last 6 months:
- ANTHONY HUNT has made 0 purchases and 18 sales selling 74,111 shares for an estimated $10,522,606.
- OLIVIER LOEILLOT (Chief Executive Officer) sold 7,041 shares for an estimated $1,196,970
- JAMES BYLUND (Chief Operating Officer) sold 2,191 shares for an estimated $331,301
- KAREN A DAWES sold 275 shares for an estimated $44,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
REPLIGEN Hedge Fund Activity
We have seen 236 institutional investors add shares of REPLIGEN stock to their portfolio, and 265 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SANDS CAPITAL MANAGEMENT, LLC removed 1,251,088 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $167,232,932
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,215,527 shares (+inf%) to their portfolio in Q4 2025, for an estimated $199,176,254
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,091,683 shares (+31.1%) to their portfolio in Q4 2025, for an estimated $178,883,176
- RTW INVESTMENTS, LP added 1,064,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $174,347,040
- FRANKLIN RESOURCES INC added 677,146 shares (+159.6%) to their portfolio in Q4 2025, for an estimated $110,957,143
- BALYASNY ASSET MANAGEMENT L.P. removed 652,186 shares (-85.0%) from their portfolio in Q4 2025, for an estimated $106,867,197
- FRED ALGER MANAGEMENT, LLC added 553,105 shares (+154.3%) to their portfolio in Q4 2025, for an estimated $90,631,785
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
REPLIGEN Congressional Stock Trading
Members of Congress have traded $RGEN stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RGEN stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
REPLIGEN Analyst Ratings
Wall Street analysts have issued reports on $RGEN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/29/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- HSBC issued a "Buy" rating on 10/01/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/03/2025
To track analyst ratings and price targets for REPLIGEN, check out Quiver Quantitative's $RGEN forecast page.
REPLIGEN Price Targets
Multiple analysts have issued price targets for $RGEN recently. We have seen 8 analysts offer price targets for $RGEN in the last 6 months, with a median target of $177.5.
Here are some recent targets:
- Dan Leonard from UBS set a target price of $200.0 on 01/16/2026
- Brandon Couillard from Wells Fargo set a target price of $190.0 on 12/15/2025
- Luke Sergott from Barclays set a target price of $200.0 on 12/15/2025
- Kyle Mikson from Canaccord Genuity set a target price of $165.0 on 10/29/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $175.0 on 10/07/2025
- Yessica Sanchez from HSBC set a target price of $150.0 on 10/01/2025
- Matthew Stanton from Jefferies set a target price of $135.0 on 09/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
